Stemness kinase

Stemness kinase製品

  • All (1)
  • Stemness kinase阻害剤 (1)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S8572 Amcasertib (BBI503) Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.
Cell Rep, 2022, 38(7):110390
Sci Rep, 2022, 12(1):7
Cell Death Dis, 2020, 11(8):670
S8572 Amcasertib (BBI503) Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.
Cell Rep, 2022, 38(7):110390
Sci Rep, 2022, 12(1):7
Cell Death Dis, 2020, 11(8):670

Stemness kinase阻害剤の選択性比較

Tags: Stemness kinase Inhibition | Stemness kinase Activation | Stemness kinase Inhibitor | Stemness kinase activator | Stemness kinase Activity | Stemness kinase phosphorylation| CSC pathway